Printer Friendly

ADA, AHA unite to encourage CVD risk factor screening.

Physicians are strongly advised to assess patients for their global risk of cardiovascular disease and diabetes, according to a "call to action" from the American Heart Association and the American Diabetes Association.

"The overweight or obese patient deserves major clinical attention. The growing prevalence of this condition threatens to undermine all of our recent gains to prevent and control chronic disease," the authors wrote (Circulation 2006;113:2943-6, Diabetes Care doi:10.2337/dc06-9911).

Cowritten by the presidents and chief science advisors of the two organizations, the document was issued in part to dispel the notion that there is disagreement between the ADA and AHA about the need to assess patients for risk factors such as prediabetes, hypertension, dyslipidemia, obesity, and smoking. In fact, the debate has been specifically about the clinical utility of the term "metabolic syndrome," not about the overall need to screen patients for risk of cardiovascular disease [CVD], they said.

"Unfortunately, some of the medical press have positioned the scientific issues related to the metabolic syndrome as a 'battle' between the [ADA and AHA], implicitly suggesting that CVD risk factor identification and treatment is now questionable. We are concerned that the presumed dispute will lead to a reduction in the favorable trend of many aspects of CVD risk factor reduction," said AHA president Dr. Robert H. Eckel and ADA president Dr. Robert Rizza, along with science advisors Richard Kahn, Ph.D., of the ADA and Dr. Rose Marie Robertson of the AHA. Another reason for issuing the statement, they noted, is the recent evidence suggesting that risk assessment and adherence to national guidelines remains "woefully suboptimal."

The ADA's free online tool at www.diabetes.org/diabetesphd includes all known CVD risk factors and can be used to predict the effects of treatment. An earlier statement about strategies for preventing CVD, cancer, and diabetes was issued jointly by the ADA, AHA, and the American Cancer Society (Diabetes Care 2004;27:1812-24, Circulation 2004;109:3244-55).

BY MIRIAM E. TUCKER

Senior Writer
COPYRIGHT 2006 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Tucker, Miriam E.
Publication:Internal Medicine News
Geographic Code:1USA
Date:Jul 15, 2006
Words:334
Previous Article:Experts nearing consensus on prehypertension.
Next Article:Cubicin.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |